A seventh member of the human beta4-galactosyltransferase family,
beta4Gal-T7, was identified by BLAST analysis of expressed sequence tags. The coding region of
beta4Gal-T7 depicts a type II transmembrane
protein with sequence similarity to beta4-galactosyltransferases, but the sequence was distinct in known motifs and did not contain the
cysteine residues conserved in the other six members of the beta4Gal-T family. The genomic organization of
beta4Gal-T7 was different from previous beta4Gal-Ts. Expression of
beta4Gal-T7 in insect cells showed that the gene product had beta1,4-galactosyltransferase activity with beta-
xylosides, and the linkage formed was Galbeta1-4Xyl. Thus,
beta4Gal-T7 represents
galactosyltransferase I enzyme (xylosylprotein beta1, 4-
galactosyltransferase; EC 2.4.1.133), which attaches the first
galactose in the
proteoglycan linkage region GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser. Sequence analysis of
beta4Gal-T7 from a fibroblast cell line of a patient with a progeroid syndrome and signs of the
Ehlers-Danlos syndrome, previously shown to exhibit reduced
galactosyltransferase I activity (Quentin, E., Gladen, A., Rodén, L., and Kresse, H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1342-1346), revealed two inherited allelic variants, beta4Gal-T7(186D) and beta4Gal-T7(206P), each with a single missense substitution in the putative catalytic domain of the
enzyme. beta4Gal-T7(186D) exhibited a 4-fold elevated K(m) for the donor substrate, whereas essentially no activity was demonstrated with beta4Gal-T7(206P). Molecular cloning of
beta4Gal-T7 should facilitate general studies of its pathogenic role in progeroid syndromes and connective tissue disorders with affected
proteoglycan biosynthesis.